Travere Therapeutics Inc (NASDAQ:TVTX)
| 20.23 BATS BZX Real-Time Price As of 9:56am ET |  +0.03 / +0.15%Today’s Change | 17.82 Today|||52-Week Range 30.35 | -3.80% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Dube Eric /glaxosmithkline/ Chief Executive Officer |  Sale | 1/24/2023 | 6,442 | $21.50 | $138.5K | -6.99% |
Dube Eric /glaxosmithkline/ Chief Executive Officer | Sale | 1/05/2023 | 5,625 | $20.75 | $116.7K | -1.41% |
Reed Elizabeth E Secretary, Senior Vice President & General Counsel | Sale | 1/24/2023 | 2,062 | $21.50 | $44.3K | -6.99% |
Rote William E Senior Vice President-Research & Development | Sale | 1/24/2023 | 2,062 | $21.50 | $44.3K | -6.99% |
Inrig Jula Chief Medical Officer | Sale | 1/04/2023 | 2,051 | $20.75 | $42.6K | -3.67% |
Heerma Peter Chief Commercial Officer | Sale | 1/24/2023 | 1,550 | $21.90 | $33.9K | -6.99% |
Calvin Sandra Chief Accounting Officer & Senior Vice President | Sale | 1/24/2023 | 905 | $21.90 | $19.8K | -6.99% |
Cline Chris Chief Financial Officer | Sale | 1/24/2023 | 852 | $21.90 | $18.7K | -6.99% |
Calvin Sandra Chief Accounting Officer & Senior Vice President | Sale | 9/13/2022 | 349 | $28.00 | $9.8K | -23.85% |
Inrig Jula Chief Medical Officer | Sale | 1/05/2023 | 442 | $20.75 | $9.2K | -1.41% |
Page of 2